Waunakee, WI, United States of America

David Gamm

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Wisconsin Alumni Research Foundation. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by David Gamm in Retinal Therapy

Introduction

David Gamm is an accomplished inventor based in Waunakee, Wisconsin. He has made significant contributions to the field of retinal therapy, particularly in the design of scaffolds for photoreceptor cell transplantation. His innovative work aims to improve the survival and integration of grafted cells, which is crucial for restoring vision.

Latest Patents

David Gamm holds a patent for a "Mechanically stable and high cell density honeycomb retinal scaffold design for transplantation therapy of photoreceptor cells and retinal pigment epithelium." This patent describes photoreceptor scaffolds that can be utilized for the transplantation of organized photoreceptor tissue, with or without retinal pigment epithelial cells. The design is intended to enhance grafted cell survival, integration, and functional visual rescue. He has 1 patent to his name.

Career Highlights

Gamm is associated with the Wisconsin Alumni Research Foundation, where he continues to advance his research and innovations. His work is pivotal in the development of therapies that could potentially restore vision to individuals suffering from retinal diseases.

Collaborations

David Gamm has collaborated with notable colleagues, including Zhenqiang Ma and Inkyu Lee. Their combined expertise contributes to the advancement of retinal therapies and the development of innovative solutions in the field.

Conclusion

David Gamm's contributions to retinal therapy through his innovative scaffold designs represent a significant advancement in the field. His work holds promise for improving the quality of life for individuals with vision impairments.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…